Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Oberling

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
Human Genetics|December 1, 1995
Germline mosaicism for an alanine to valine substitution at residue beta 140 in hemoglobin Puttelange, a new variant with high oxygen affinityH Wajcman, E Girodon, D Promé, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and reviewF Maloisel, P Dufour, J Waller, et al.
European Journal of Gynaecological Oncology|January 1, 1991
High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual diseaseP Dufour, J P Bergerat, K L Liu, et al.
La Nouvelle Presse Medicale|October 23, 1982
[Idiopathic thrombocytopenic purpura. Treatment by intravenous transfusion of polyvalent immunoglobulins]A Faradji, J M Lang, A Boilletot, et al.
Archives Francaises De Pediatrie|August 1, 1983
[Surgical correction of interventricular communication with pulmonary stenosis in a hemophiliac]A Boilletot, B De Geeter, M L Wiesel, et al.
Gynecologic Oncology|October 29, 1998
Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot studyJ E Kurtz, G Deplanque, B Duclos, et al.
Leukemia & Lymphoma|July 1, 1996
Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphomaP Dufour, R Mors, P Berthaud, et al.
Oncology Reports|October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effectsB Cutuli, T Petit, S Hoffstetter, et al.
Bulletin Du Cancer|July 1, 1996
[Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]T Petit, P Dufour, J C Barrats, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcomaO Feugeas, N Guriec, A Babin-Boilletot, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Human Genetics|December 1, 1995
Germline mosaicism for an alanine to valine substitution at residue beta 140 in hemoglobin Puttelange, a new variant with high oxygen affinityH Wajcman, E Girodon, D Promé, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and reviewF Maloisel, P Dufour, J Waller, et al.
European Journal of Gynaecological Oncology|January 1, 1991
High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual diseaseP Dufour, J P Bergerat, K L Liu, et al.
La Nouvelle Presse Medicale|October 23, 1982
[Idiopathic thrombocytopenic purpura. Treatment by intravenous transfusion of polyvalent immunoglobulins]A Faradji, J M Lang, A Boilletot, et al.
Archives Francaises De Pediatrie|August 1, 1983
[Surgical correction of interventricular communication with pulmonary stenosis in a hemophiliac]A Boilletot, B De Geeter, M L Wiesel, et al.
Gynecologic Oncology|October 29, 1998
Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot studyJ E Kurtz, G Deplanque, B Duclos, et al.
Leukemia & Lymphoma|July 1, 1996
Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphomaP Dufour, R Mors, P Berthaud, et al.
Oncology Reports|October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effectsB Cutuli, T Petit, S Hoffstetter, et al.
Bulletin Du Cancer|July 1, 1996
[Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]T Petit, P Dufour, J C Barrats, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcomaO Feugeas, N Guriec, A Babin-Boilletot, et al.
Pageof 21